Company Pipeline

Immune Design’s pipeline includes our preclinical stage therapeutic vaccine candidate for genital herpes – GLA-HSV (up to three recombinant antigens in combination with GLA adjuvant), and our preclinical therapeutic vaccine candidate for cancer utilizing our ID-LV platform. 

Immune Design Product Pipeline (As of November 2012)